Low Dose GC4419: 30mg/day
GT-201
Phase 2 small_molecule completed
Quick answer
Low Dose GC4419: 30mg/day for Radiation Induced Oral Mucositis is a Phase 2 program (small_molecule) at Galera Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Galera Therapeutics
- Indication
- Radiation Induced Oral Mucositis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed